Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-109417
Filing Date
2023-10-16
Accepted
2023-10-16 17:23:23
Documents
8
Effectiveness Date
2023-10-16

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2328410d1_s8.htm S-8 65336
2 EXHIBIT 5.1 tm2328410d1_ex5-1.htm EX-5.1 11006
3 EXHIBIT 23.1 tm2328410d1_ex23-1.htm EX-23.1 3013
4 EXHIBIT 23.2 tm2328410d1_ex23-2.htm EX-23.2 2061
5 EX-FILING FEES tm2328410d1_ex107.htm EX-FILING FEES 23881
6 GRAPHIC tm2328410d1_ex5-1img001.jpg GRAPHIC 4771
7 GRAPHIC tm2328410d1_ex23-1img001.jpg GRAPHIC 2257
8 GRAPHIC tm2328410d1_ex23-1img002.jpg GRAPHIC 1836
  Complete submission text file 0001104659-23-109417.txt   119110
Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Filer) CIK: 0001826667 (see all company filings)

EIN.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-275009 | Film No.: 231328022
SIC: 3841 Surgical & Medical Instruments & Apparatus